Elicio Therapeutics (ELTX) Return on Assets (2021 - 2026)
Elicio Therapeutics' (ELTX) quarterly Return on Assets came in at 0.03% in Q1 2026, down 1.0% YoY from 0.03% in Q1 2025, and down 34.09% on a QoQ basis from 0.02% in Q4 2025.
Elicio Therapeutics (ELTX) Return on Assets (2021 - 2026) Analysis & Trends
Elicio Therapeutics (ELTX) has 6 years of Return on Assets data on file, last reported at 0.03% in Q1 2026.
- Quarterly Return on Assets fell 1.0% year-over-year to 0.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03% (down 1.0% YoY) and the FY2025 annual result came in at 0.02%, up 4.0% from the prior year.
- Return on Assets declined to 0.03% in Q1 2026, from 0.02% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q3 2022 to a low of 0.03% in Q2 2024.
- A 5-year average of 0.02% and a median of 0.02% in 2023 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2022 — Return on Assets gained 1 bps — and 2024, when it fell 2 bps.
- Tracing ELTX's Return on Assets over 5 years: stood at 0.01% in 2022, then slumped by 84 bps to 0.02% in 2023, then climbed by 6 bps to 0.02% in 2024, then declined by 29 bps to 0.02% in 2025, then tumbled by 34 bps to 0.03% in 2026.
- The last three Return on Assets figures came in at 0.03% (Q1 2026), 0.02% (Q4 2025), and 0.02% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Elicio Therapeutics | 59.08 Mn | 35.58 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.02% |
| Mar 31, 2026 | -0.03% |
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.03% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |